Table 1 Pooled prevalence of MHS in LMICs
Variable | No. of studies (with MHS coverage) | Pooled prevalence (95% CI) | Minimum prevalence (95% CI) | Maximum prevalence (95% CI) | Quantifying heterogeneity | Q statistics (p-value) | |
|---|---|---|---|---|---|---|---|
\({\tau }^{2}(95\text{\% CI})\) | \({I}^{2}(\%)\) | ||||||
ANC1 | 66 | 85.0 (81.2, 88.1) | 46.1 (42.3, 50.0) | 98.7 (98.7, 98.8) | 1.22 (0.89, 1.81) | 99.9 | 84,538.1 (< 0.001) |
ANC4 | 108 | 50.8 (46.4, 55.2) | 10.5 (8.0, 13.4) | 90.9 (89.7, 92.0) | 0.87 (0.68, 1.17) | 100.0 | 249,820.9 (< 0.001) |
SBA | 42 | 65.6 (58.7, 71.9) | 16.2 (15.4, 17.1) | 93.6 (92.9, 94.3) | 0.94 (0.64, 1.54) | 100.0 | 537,714.3 (< 0.001) |
ID | 63 | 66.9 (60.3, 72.9) | 11.3 (10.6, 12.1) | 99.8 (99.7, 100) | 1.34 (0.99, 2.09 | 100.0 | 393,017.0 (< 0.001) |
PNC | 37 | 48.9 (41.7, 56.2) | 14.3 (11.2, 17.9) | 85.0 (81.9, 87.8) | 0.82 (0.54, 1.40) | 100.0 | 147,604.2 (< 0.001) |